CATX Perspective Therapeutics, Inc.

NEUTRAL Impact: 2/10 8-K
Horizon days Filed May 4, 2026 Processed 1mo ago SEC 0001193125-26-204161
8-K Item 2.02: Earnings release
Latest settled — T+20d
CATX ▼ -1.37% at T+20d
NEUTRAL call ✗ call lost -1.37% · α vs SPY -6.32% · entry $3.65 → $3.60
Next anchor: T+60d in 7w
Currently $2.95 · -19.18% from $3.65 entry
Entry anchored
May 4, 2026
via day open
T+1d
+4.66%
call +4.66% · α +3.27%
$3.82
settled 6w ago
T+5d
+3.29%
call +3.29% · α +1.30%
$3.77
settled 5w ago
T+20d
-1.37%
call -1.37% · α -6.32%
$3.60
settled 11d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Perspective Therapeutics filed an 8-K reporting that it posted a presentation with estimated cash, cash equivalents, and short-term investments as of March 31, 2026, which are preliminary and unaudited. No actual financial results or guidance were disclosed, making this a routine update with limited material information.

Actionable Insight

Monitor the upcoming Q1 2026 10-Q for actual financial results and cash position. The preliminary cash estimate from this analyst day presentation is unlikely to drive stock movement without additional context.

Key Facts

  • Filing 8-K with Items 2.02 and 8.01, related to an analyst event presentation posted on May 4, 2026.
  • Presentation contains estimated cash, cash equivalents, and short-term investments as of March 31, 2026, which are preliminary and unaudited.
  • No actual Q1 2026 revenue, EPS, or other financial results are reported in this filing.
  • Company had ~$145M cash at FY2025 end and completed a ~$164M equity offering in February 2026.

Financial Impact

No financial figures are disclosed in the filing—only preliminary estimated cash data.

cash

Risk Factors

  • Preliminary data may differ materially from final reported results.
  • No new operational or clinical milestones were announced.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-204161
Document: catx-ex99_1.htm0001193125-26-204161
Document: 0001193125-26-204161-index-headers.html0001193125-26-204161
Document: 0001193125-26-204161-index.html0001193125-26-204161
Document: 0001193125-26-204161.txt0001193125-26-204161
8-K Data (Synthetic)0001193125-26-204161
13 reports for CATX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CATX — sortable, filterable
Type Now
Jun 12, 2026
1d ago
Institutional Cluster
BULLISH ★ 5/10
$2.96 awaiting T+1awaiting T+1$2.95 (−0.34%)
Jun 11, 2026
1d ago
Institutional Cluster
NEUTRAL ★ 4/10
$2.96 awaiting T+1awaiting T+1$2.95 (−0.17%)
Jun 3, 2026
10d ago
Press Release
NEUTRAL ★ 5/10
$3.56 $3.25▼ −8.71%▼ −9.11%$2.95 (−17.13%)
Jun 1, 2026
12d ago
8-K
NEUTRAL ★ 3/10
$3.66 $3.60▼ −1.64%▼ −1.78%$2.95 (−19.40%)
May 21, 2026
22d ago
Press Release
NEUTRAL ★ 4/10
$3.98 $4.16▲ +4.52%▲ +3.94%$2.95 (−25.88%)
May 18, 2026
26d ago
Press Release
NEUTRAL ★ 3/10
$3.76 $3.63▼ −3.46%▼ −2.81%$2.95 (−21.54%)
May 11, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$3.77 $3.77· 0.00%▼ −0.54%$2.95 (−21.75%)
May 4, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$3.65 $3.82▲ +4.66%▲ +3.27%$2.95 (−19.18%)
Apr 24, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$4.51 $4.27▼ −5.32%▼ −5.49%$2.95 (−34.59%)
Apr 20, 2026
7w ago
Press Release
BULLISH ★ 7/10
$4.55 $4.64▲ +1.98%▲ +2.63%$2.95 (−35.16%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (49h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access